1. Home
  2. MGTX vs SBGI Comparison

MGTX vs SBGI Comparison

Compare MGTX & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.22

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Sinclair Inc.

SBGI

Sinclair Inc.

HOLD

Current Price

$12.08

Market Cap

909.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGTX
SBGI
Founded
2015
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
909.8M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
MGTX
SBGI
Price
$9.22
$12.08
Analyst Decision
Buy
Hold
Analyst Count
8
7
Target Price
★ $27.75
$17.57
AVG Volume (30 Days)
★ 819.2K
443.1K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
★ 8.07%
EPS Growth
★ 33.02
N/A
EPS
★ 1.30
N/A
Revenue
$81,391,000.00
★ $3,169,000,000.00
Revenue This Year
$314.19
$11.11
Revenue Next Year
N/A
N/A
P/E Ratio
$7.09
★ N/A
Revenue Growth
★ 144.57
N/A
52 Week Low
$6.62
$12.23
52 Week High
$15.35
$17.88

Technical Indicators

Market Signals
Indicator
MGTX
SBGI
Relative Strength Index (RSI) 31.90 38.23
Support Level $8.84 N/A
Resistance Level $10.06 $14.50
Average True Range (ATR) 0.52 0.46
MACD 0.01 -0.00
Stochastic Oscillator 6.12 6.57

Price Performance

Historical Comparison
MGTX
SBGI

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About SBGI Sinclair Inc.

Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay TV distributors.

Share on Social Networks: